Cargando…

Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes

Type 2 Diabetes Mellitus (T2DM) is a chronic progressive disease, defined by insulin resistance and insufficient insulin secretion to maintain normoglycemia. Amyloidogenic aggregates are a hallmark of T2DM patients; they are cytotoxic for the insulin producing β-cells, and cause inflammasome-depende...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vogt, Anne-Cathrine S., Roesti, Elisa S., Mohsen, Mona O., Leonchiks, Ainars, Vogel, Monique, Bachmann, Martin F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622146/ https://www.ncbi.nlm.nih.gov/pubmed/34835247 http://dx.doi.org/10.3390/vaccines9111316

Ejemplares similares

Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2023)

Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2022)

On Iron Metabolism and Its Regulation
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2021)

Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2022)

Sorting out the Superbugs: Potential of Sortase A Inhibitors among Other Antimicrobial Strategies to Tackle the Problem of Antibiotic Resistance
por: Zrelovs, Nikita, et al.
Publicado: (2021)

Apolipoprotein E Interferes with IAPP Aggregation and Protects Pericytes from IAPP-Induced Toxicity
por: Gharibyan, Anna L., et al.
Publicado: (2020)

The Role of Glycation on the Aggregation Properties of IAPP
por: Milordini, Giulia, et al.
Publicado: (2020)

Myricetin Inhibits Islet Amyloid Polypeptide (IAPP) Aggregation and Rescues Living Mammalian Cells from IAPP Toxicity
por: Zelus, Casey, et al.
Publicado: (2012)

Anti‐murine Antibody Response to Mouse Monoclonal Antibodies in Cancer Patients
por: Sakahara, Harumi, et al.
Publicado: (1997)

Human IAPP is a contributor to painful diabetic peripheral neuropathy
por: Albariqi, Mohammed M.H., et al.
Publicado: (2023)

Mechanisms of Transthyretin Inhibition of IAPP Amyloid Formation
por: Wasana Jayaweera, Sanduni, et al.
Publicado: (2021)

Intranasal administration of a VLP‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern
por: Rothen, Dominik A., et al.
Publicado: (2022)

Sub-stoichiometric inhibition of IAPP aggregation: a peptidomimetic approach to anti-amyloid agents
por: Maity, Debabrata, et al.
Publicado: (2020)

SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
por: Bachmann, Martin F., et al.
Publicado: (2021)

Human Islet Amyloid Polypeptide (hIAPP) Protofibril‐Specific Antibodies for Detection and Treatment of Type 2 Diabetes
por: Bortoletto, Angelina S., et al.
Publicado: (2022)

A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models
por: Wirth, Fabian, et al.
Publicado: (2023)

Conformational Ensemble of hIAPP Dimer: Insight into the Molecular Mechanism by which a Green Tea Extract inhibits hIAPP Aggregation
por: Mo, Yuxiang, et al.
Publicado: (2016)

Structural basis for the inhibition of IAPP fibril formation by the co-chaperonin prefoldin
por: Törner, Ricarda, et al.
Publicado: (2022)

Efficacy of IAPP suppression in mouse and human islets by GLP-1 analogue conjugated antisense oligonucleotide
por: Gurlo, Tatyana, et al.
Publicado: (2023)

Factors That Contribute to hIAPP Amyloidosis in Type 2 Diabetes Mellitus
por: Sevcuka, Adriana, et al.
Publicado: (2022)

Urolithin B: Two-way attack on IAPP proteotoxicity with implications for diabetes
por: Raimundo, Ana F., et al.
Publicado: (2022)

Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives
por: Pithadia, Amit, et al.
Publicado: (2016)

Effect of DNA Origami Nanostructures on hIAPP Aggregation
por: Hanke, Marcel, et al.
Publicado: (2020)

Epitope mapping of anti-mouse podoplanin monoclonal antibody PMab-1
por: Yamada, Shinji, et al.
Publicado: (2018)

Generation and Validation of an Anti-Human PANK3 Mouse Monoclonal Antibody
por: Khadka, Sunada, et al.
Publicado: (2022)

On the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP Peptides
por: Tomasello, Marianna Flora, et al.
Publicado: (2015)

Effect of IAPP on the proteome of cultured Rin-5F cells
por: Miraee-Nedjad, Samaneh, et al.
Publicado: (2018)

Structural Insight into IAPP‐Derived Amyloid Inhibitors and Their Mechanism of Action
por: Niu, Zheng, et al.
Publicado: (2020)

iApp: An Autonomous Inspection, Auscultation, Percussion, and Palpation Platform
por: Ryu, Semin, et al.
Publicado: (2022)

Bleomycin modulates amyloid aggregation in β-amyloid and hIAPP
por: Kumari, Anchala, et al.
Publicado: (2020)

Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics
por: Abedini, Andisheh, et al.
Publicado: (2016)

Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus
por: Roesti, Elisa S., et al.
Publicado: (2020)

Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles
por: Chang, Xinyue, et al.
Publicado: (2022)

The redox environment triggers conformational changes and aggregation of hIAPP in Type II Diabetes
por: Rodriguez Camargo, Diana C., et al.
Publicado: (2017)

Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism
por: Mukherjee, Abhisek, et al.
Publicado: (2017)

IAPP-induced beta cell stress recapitulates the islet transcriptome in type 2 diabetes
por: Blencowe, Montgomery, et al.
Publicado: (2021)

Characterization of 7A7, an anti-mouse EGFR monoclonal antibody proposed to be the mouse equivalent of cetuximab
por: He, Xuzhi, et al.
Publicado: (2018)

Establishment of anti-mesothelioma monoclonal antibodies
por: Mizutani, Natsuko, et al.
Publicado: (2016)

Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2019)

Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies
por: Ganesan, Rajkumar, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eusb1stut9f6n4rku1ptq5nd9n